Events Search and Views Navigation
February 2013
Multi stakeholder meeting on Adaptive Licensing
Could AL become an IMI call topic?Gigi Hirsch (MIT) and Thomas Unger (Pfizer).
Find out more »March 2013
Progressive development and patient access
IMI project development meetingGigi Hirsch (MIT) and Thomas Unger (Pfizer)
Find out more »April 2013
BIO 2013
“Adaptive Development Strategies for Managed Entry of New Medicines”Panel Discussants: Robyn Lim (Health Canada), Kenneth Oye (MIT), and Thomas Unger (Pfizer).
Find out more »Healthcare Ecosystem @MIT
Keynote speakers: Gigi Hirsch (MIT) and Robert Langer (MIT).
Find out more »EFPIA/IMI planning session for Task Force on Progressive Patient Access
Gigi Hirsch and Lynn Baird (MIT)
Find out more »May 2013
11th Annual FEI: Front End Innovation
NEWDIGSPanel Discussants: Gigi Hirsch (MIT), Ed Pezalla (Aetna), and Thomas Unger (Pfizer).
Find out more »June 2013
DIA
“Progressive Patient Access (adaptive licensing) How could pilots look taking the new EU-PV legislation into account?”Dr. Anton (Tony) Hoos (GlaxoSmithKline)
Find out more »CancerRX Conference
(Chaired by Prof. Andrew Lo).Panel Discussants: New Business Models/NEWDIGS Gigi Hirsch (MIT) and Thomas Unger (Pfizer)
Find out more »September 2013
Special Executive Briefing on NEWDIGS/Adaptive Licensing Program (regulators-only)
Session Co-Leads: Gigi Hirsch and Ken Oye (MIT)
Find out more »IOM Roundtable on Value and Science-Driven Healthcare
Regulatory Science & Practice: Overview of Adaptive Licensing.Ed Pezalla (Aetna).
Find out more »